BiotechTube

Duloxetine 60 mg + Placebo

Phase 3Completed
2 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fibromyalgia

Conditions

Fibromyalgia

Trial Timeline

Mar 1, 2012 → Dec 1, 2013

NCT ID
NCT01552057

About Duloxetine 60 mg + Placebo

Duloxetine 60 mg + Placebo is a phase 3 stage product being developed by Shionogi for Fibromyalgia. The current trial status is completed. This product is registered under clinical trial identifier NCT01552057. Target conditions include Fibromyalgia.

What happened to similar drugs?

11 of 20 similar drugs in Fibromyalgia were approved

Approved (11) Terminated (3) Active (9)
✅zonisamideEisaiApproved
✅DuloxetineEli LillyApproved
✅duloxetine hydrochloride + placeboEli LillyApproved
✅Duloxetine + PlaceboEli LillyApproved
✅Eszopiclone + placeboSumitomo PharmaApproved
✅QuetiapineAstraZenecaApproved
✅amitriptyline + quetiapineAstraZenecaApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01552057Phase 3Completed

Competing Products

20 competing products in Fibromyalgia

See all competitors
ProductCompanyStageHype Score
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
DS-5565Daiichi SankyoPhase 3
40
DS-5565 + PlaceboDaiichi SankyoPhase 3
40
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
DS-5565 + Pregabalin + Placebo tablet + Placebo capsuleDaiichi SankyoPhase 3
40
ASP8062 + PlaceboAstellas PharmaPhase 2
35
ASP0819 + PlaceboAstellas PharmaPhase 2
35
DuloxetineShionogiPhase 3
40
zonisamideEisaiApproved
35
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
42
DuloxetineEli LillyApproved
35
duloxetine hydrochloride + placeboEli LillyApproved
43
duloxetineEli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyPhase 3
40
Duloxetine + PlaceboEli LillyApproved
43
Treatment for FibromyalgiaEli LillyPre-clinical
26
Duloxetine + PlaceboEli LillyPhase 3
40
duloxetine + placeboEli LillyPhase 3
40
Eszopiclone + placeboSumitomo PharmaApproved
43